Shandong Jincheng Pharmaceutical Group Dividend
Dividend criteria checks 4/6
Shandong Jincheng Pharmaceutical Group is a dividend paying company with a current yield of 1.85% that is well covered by earnings. Next payment date is on 20th September, 2024 with an ex-dividend date of 20th September, 2024.
Key information
1.9%
Dividend yield
57%
Payout ratio
| Industry average yield | 2.1% |
| Next dividend pay date | 20 Sep 24 |
| Ex dividend date | 20 Sep 24 |
| Dividend per share | CN¥0.200 |
| Earnings per share | CN¥0.54 |
| Dividend yield forecast | n/a |
Recent dividend updates
Recent updates
Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Popularity With Investors Is Under Threat From Overpricing
Jun 07
Shandong Jincheng Pharmaceutical Group's (SZSE:300233) Problems Go Beyond Weak Profit
Apr 04Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Shares Climb 29% But Its Business Is Yet to Catch Up
Mar 04Shandong Jincheng Pharmaceutical Group (SZSE:300233) Seems To Use Debt Quite Sensibly
Mar 02Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300233's dividend payments have been volatile in the past 10 years.
Growing Dividend: 300233's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Shandong Jincheng Pharmaceutical Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300233) | 1.9% |
| Market Bottom 25% (CN) | 0.8% |
| Market Top 25% (CN) | 2.8% |
| Industry Average (Pharmaceuticals) | 2.1% |
| Analyst forecast (300233) (up to 3 years) | n/a |
Notable Dividend: 300233's dividend (1.85%) is higher than the bottom 25% of dividend payers in the CN market (0.76%).
High Dividend: 300233's dividend (1.85%) is low compared to the top 25% of dividend payers in the CN market (2.82%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (56.7%), 300233's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (27.3%), 300233's dividend payments are well covered by cash flows.